Zika linked to temporary muscle paralysis in French Polynesia

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

A new study of 42 cases of Guillain-Barré syndrome in French Polynesia offers the strongest evidence to date that the Zika virus can trigger temporary paralysis, researchers reported. But experts cautioned that more evidence from other locations was needed to be conclusive.

Since last year, doctors have noticed an unusual increase in Guillain-Barré cases in several countries with Zika outbreaks, including Brazil, El Salvador and Venezuela. But as the World Health Organization reported, a large number of those patients have not yet been confirmed through laboratory testing to have Zika.

Guillain-Barré leaves patients unable to move, in extreme cases forcing them to depend on life support. While most patients eventually regain full movement, the condition can be fatal. In the patients studied in French Polynesia, none died, but 38 percent went to an intensive care unit and 29 percent needed help breathing.

Researchers used a gold-standard test to look for Zika antibodies in the patients. It entailed adding serum from each patient to live Zika virus in a culture, and then seeing whether the patient had antibodies to destroy the virus.

All 42 patients had antibodies that killed the Zika virus. By contrast, only half of a control group of 98 people — matched for age, sex, and residence — had the antibodies.

The scientists also looked for another type of antibody, called IgM, to see if patients had recently been infected with Zika. Thirty one patients, nearly 74 percent, had IgM antibodies against Zika.

Read full, original post: New Study Links Zika Virus to Temporary Paralysis

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Supplement Rain Wellness Illustration
Viewpoint: Bedeviled by “toxic inflammation”? How wellness grifters turn this scientific gray zone into a supplement jackpot
Wave Crest Over Red Cross
Viewpoint: Here are the election-inspired Trump administration healthcare policy reversals expected in the coming months
Teal Hexagon Technology Icons
4 key ways the Blue Wave will upend science policy
Aerial Sprayer Over Gradient Fields
Farming, food, and chemicals: Post-midterms, the MAHA alliance between Democrats and MAGA Republicans is bruised but not cowed. What comes next?
Confident Doctor in Clinical Setting
More than 80% of ‘pro-science’ candidates were swept into office. Will they have a policy impact?
Stacked Protest Signs on Concrete Ledge
Voters hate AI data centers, yet they are crucial to establishing a critical technology. So what’s next?
Microscopic IVF Egg Injection
With technical barriers to human embryo editing falling, ethical concerns escalate
Protect-Womens-Sports-at-the-Capitol
Blue, purple and red states passed or reaffirmed bans on trans females competing in women’s sports
Democratic Donkey Plowing at Sunset
Viewpoint: Democratic tsunami: As the red tide recedes, here are the most likely shifts in food and agricultural policy
Screenshot-2026-11-05-at-1.20.54-PM
$7.35 billion PFAS settlement: 3M to pay people who blame health problems on ‘forever chemicals’ phased out of firefighting foam for more than 20 years
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.